These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 724319
1. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies. Buchanan GR, Kevy SV. Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319 [Abstract] [Full Text] [Related]
2. Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors. Abildgaard CF, Britton M, Harrison J. J Pediatr; 1976 Feb; 88(2):200-5. PubMed ID: 1249680 [Abstract] [Full Text] [Related]
3. Increased fibrinopeptide A after prothrombin complex concentrates. Viganó S, Cattaneo M, Gervasoni W, Mannucci PM. Thromb Haemost; 1980 Oct 31; 44(2):72-5. PubMed ID: 6779400 [Abstract] [Full Text] [Related]
11. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital]. Diniz MJ, Dias Francisco F, Tavares ML, Leal I. Acta Med Port; 1992 Apr 31; 5(4):178-80. PubMed ID: 1605065 [Abstract] [Full Text] [Related]
12. Hemophilia. Strategies for the treatment of inhibitor patients. Ingerslev J. Haematologica; 2000 Oct 31; 85(10 Suppl):15-20. PubMed ID: 11187863 [Abstract] [Full Text] [Related]
13. Editorial: Factor VIII inhibitors. Deykin D. N Engl J Med; 1974 Jul 25; 291(4):205. PubMed ID: 4834491 [No Abstract] [Full Text] [Related]
14. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII]. Shima M, Sawamoto Y, Kamisue M, Shibata Y, Tuzi S, Kuwabara M, Tanaka I, Tanizawa T, Tanaka A, Ueda M, Kakishita E, Yoshioka A. Rinsho Ketsueki; 1996 Nov 25; 37(11):1303-8. PubMed ID: 8960666 [Abstract] [Full Text] [Related]
15. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center. Kershaw G, Jayakodi D, Dunkley S. Semin Thromb Hemost; 2009 Nov 25; 35(8):760-8. PubMed ID: 20169512 [Abstract] [Full Text] [Related]
18. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma. Orstavik KH. Thromb Haemost; 1981 Dec 23; 46(4):684-6. PubMed ID: 7330818 [Abstract] [Full Text] [Related]
19. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX]. Niiya K, Hirose S, Taguchi H, Miyoshi I. Rinsho Ketsueki; 1985 Jun 23; 26(6):980-4. PubMed ID: 3877825 [No Abstract] [Full Text] [Related]
20. [Paradoxical bleeding as a complication of the treatment of hemophilia with factor VIII and factor IX preparations]. Sutor AH. Folia Haematol Int Mag Klin Morphol Blutforsch; 1990 Jun 23; 117(4):595-9. PubMed ID: 1714865 [Abstract] [Full Text] [Related] Page: [Next] [New Search]